Literature DB >> 17953422

Update on the role of EGFR inhibitors in cancer therapeutics.

Michalis V Karamouzis1, Athanassios Argiris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17953422     DOI： 10.1007/978-0-387-69219-7_19

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  1 in total

1.  EML4-ALK fusion lung cancer: a rare acquired event.

Authors:  Sven Perner; Patrick L Wagner; Francesca Demichelis; Rohit Mehra; Christopher J Lafargue; Benjamin J Moss; Stefanie Arbogast; Alex Soltermann; Walter Weder; Thomas J Giordano; David G Beer; David S Rickman; Arul M Chinnaiyan; Holger Moch; Mark A Rubin
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.